Moderna reported new clinical data on its COVID-19 vaccine
On Sept. 15, 2021, Moderna announced new analysis suggesting that the Moderna COVID-19 vaccine was highly effective against…
City of Hope trial was first to test an investigational COVID-19 vaccine in immunocompromised bone marrow transplant
On Sept. 14, 2021, City of Hope announced that it had begun enrolling patients in a Phase 2…
Adamis publication demonstrated Tempol significantly inhibited multiple cytokines from COVID-19 patientï¾’s cells
On Aug. 24, 2021, Adamis Pharma announced publication in the peer reviewed journal, Clinical Immunology, entitled ﾓTempol, a…
FDA Approved Expanded BOTOX® Label to Include Eight New Muscles to Treat Adults with Upper Limb Spasticity
On Jul. 29, 2021, BOTOX(R) Allergan, an AbbVie company, announced that the U.S. Food and Drug Administration (FDA)…
NIH COVID-19 testing initiative funded additional research projects to safely return children to in-person school
On Jul. 2, 2021, the National Institutes of Health funding five additional projects to identify ways of safely…
Icosavax initiated phase 1/2 trial of COVID-19 VLP vaccine candidate
On Jun. 8, 2021, Icosavax announced the first subjects had been dosed with IVX-411, a virus-like particle (VLP)…
FDA approved LUMAKRAS for patients with KRAS G12C-mutated locally advanced or metastatic non-small cell lung cancer
On May 28, 2021, Amgen announced that the FDA had approved LUMAKRAS (sotorasib) for the treatment of adult…
Thermo Fisher and University of California, San Francisco announced cell therapy cGMP manufacturing and collaboration center
On May 19, 2021, Thermo Fisher Scientific and the University of California, San Francisco (UCSF) announced they have…
Precipio launched Rapid COVID-19 Antibody test on Amazon platform
On May 3, 2021, Precipio announced that it had successfully launched its COVID-19 rapid antibody test (20 minute)…
TGen study predicted changing Lyme disease habitat across the West Coast
On Mar. 16, 2021, TGen announced a study that suggested ecosystems suitable for harboring ticks that carry debilitating…
The US Department of Defense identified more troops to help administer COVID-19 vaccine
On Mar. 10, 2021, the U.S. Department of Defense (DOD) announced that it had identified additional personnel authorized…
NeuroRx initiated phase 2/3 study of inhaled ZYESAMI for severe COVID-19 with UCI Health
On Feb. 3, 2021, RELIEF THERAPEUTICS affirmed that its collaboration partner NeuroRx had initiated a phase 2/3 clinical…
Adamis Pharma and Stanford University announced preliminary Tempol data in cells from COVID-19 patients
On Jan. 28, 2021, Adamis Pharma in collaboration with the Human Immune Monitoring Center at Stanford University have…
Ajinomoto Bio-Pharma and Humanigen expanded agreement to support fill finish for COVID-19 therapeutic
On Jan. 27, 2021, Ajinomoto Bio-Pharma Services and Humanigen announced the companies will be expanding their manufacturing agreement…
Vaxart announced additional preclinical COVID-19 oral vaccine data and publication
On Jan. 26, 2021, Vaxart announced additional results from its SARS-CoV-2 Hamster Challenge Study, as well as a…
The USDA confirmed COVID-19 in gorillas at San Diego Zoo Safari Park
On Jan. 13, 2021, the USDAï¾’s (USDA) National Veterinary Services Laboratories announced confirmation of SARS-CoV-2 (the virus that…
First evidence of UK coronavirus variant in California confirmed by Scripps Research lab
On Jan. 4, 2021, a research partnership between scientists at Scripps Research and UC San Diego found the…
CIRM-funded project targeting sickle cell disease received green light for clinical trial
On Dec.14, 2020, the US Food and Drug Administration (FDA) announced they had granted Investigational New Drug (IND)…
LA County launched holiday COVID-19 home test collection pilot
On Dec. 4, 2020, Los Angeles County launched a new COVID-19 home test collection program, which allowed certain…
FDA approved first PSMA-targeted PET imaging drug for men with prostate cancer
On Dec. 1, 2020, the FDA approved Gallium 68 PSMA-11 (Ga 68 PSMA-11) ï¾– the first drug for…
FDA expanded approval of influenza treatment to post-exposure prevention
On Nov. 23, 2020, the FDA expanded the approved indication for Genentech’s Xofluza (baloxavir marboxil) to include post-exposure…
Genentech announced FDA Approval of Xofluza for prevention of influenza following contact with infected person
On Nov. 23, 2020, Genentech announced that the FDA had approved a supplemental New Drug Application (sNDA) for…
Gilead announced long-acting HIV-1 capsid inhibitor, lenacapavir, achieved primary endpoint in phase 2/3 study
On Nov. 18, 2020, Gilead Sciences announced topline results from the Phase 2/3 CAPELLA trial evaluating the company’s…
CIRM Board approved four new clinical trials
On Nov.12, 2020, the governing Board of the California Institute for Regenerative Medicine (CIRM) approved four new clinical…
ImmunityBio, NantKwest announced positive interim phase 1 safety data of hAd5 COVID-19 vaccine dose study
On Nov. 10, 2020, ImmunityBio and NantKwest, a clinical-stage, natural killer cell-based therapeutics company, announced they had administered…
Single-cell study of Ebola highlighted virus’s lethal maneuvers
On Nov. 6, 2020, in a study published in Cell, the researchers identified antiviral defense genes that the…
Stanford developed CRISPR ‘lab on a chip’ for detecting COVID-19
On Nov. 4, 2020, using the cutting-edge genetic editing technique known as CRISP ﾓlab on a chipï¾” technology,…
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Life Science News | Non-Profit Research
UC Berkeley launched pop-up lab to monitor Bay Area sewage for COVID-19
On Oct. 29, 2020, UC Berkeley announced that it had launched a new high-throughput pop-up lab – a…
Vacaville unveiled California Biomanufacturing Center and next generation of biotech development
On Oct. 22, 2020, the City of Vacaville announced the start of the next generation of development of…
Entos announced spin-off company Aegis Life to support global vaccine commercialization
On Oct. 15, 2020, Entos Pharmaceuticals announces that its San Diego-based spinout company Aegis Life, will pursuing U.S….